These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24939538)

  • 1. [New physiopathological roles for the PLA2R1 receptor in cancer and membranous nephropathy].
    Girard CA; Seitz-Polski B; Dolla G; Augert A; Vindrieux D; Bernard D; Lambeau G
    Med Sci (Paris); 2014 May; 30(5):519-25. PubMed ID: 24939538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role.
    Liu W; Gao C; Dai H; Zheng Y; Dong Z; Gao Y; Liu F; Zhang Z; Liu Z; Liu W; Liu B; Liu Q; Shi J
    Front Immunol; 2019; 10():1809. PubMed ID: 31447839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients.
    Seitz-Polski B; Payré C; Ambrosetti D; Albano L; Cassuto-Viguier E; Berguignat M; Jeribi A; Thouret MC; Bernard G; Benzaken S; Lambeau G; Esnault VL
    Nephrol Dial Transplant; 2014 Dec; 29(12):2334-42. PubMed ID: 25063424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Membranous nephropathy: Pathophysiology and natural history].
    Seitz-Polski B; Lambeau G; Esnault V
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S75-S81. PubMed ID: 28577747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy.
    Dähnrich C; Komorowski L; Probst C; Seitz-Polski B; Esnault V; Wetzels JF; Hofstra JM; Hoxha E; Stahl RA; Lambeau G; Stöcker W; Schlumberger W
    Clin Chim Acta; 2013 Jun; 421():213-8. PubMed ID: 23541686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1.
    Schlumberger W; Hornig N; Lange S; Probst C; Komorowski L; Fechner K; Dähnrich C; Stöcker W
    Autoimmun Rev; 2014 Feb; 13(2):108-13. PubMed ID: 24075959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a novel rat model of off-target PLA2R1 knockout to renal impairment.
    Huang B; Zhang Z; Sui W; Zhao L; Li Y; Feng L; Yang D; Zhou Y
    Genomics; 2024 Mar; 116(2):110796. PubMed ID: 38237745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy.
    Seitz-Polski B; Dolla G; Payré C; Tomas NM; Lochouarn M; Jeammet L; Mariat C; Krummel T; Burtey S; Courivaud C; Schlumberger W; Zorzi K; Benzaken S; Bernard G; Esnault VL; Lambeau G
    Biochimie; 2015 Nov; 118():104-15. PubMed ID: 26296473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reappraisal of PLA2R1 in membranous nephropathy: immunostaining method influence and association with IgG4-dominant phenotype.
    Hara S; Goto S; Kamiura N; Yoshimoto A; Naito T; Imagawa N; Imai Y; Yanagita M; Nishi S; Itoh T
    Virchows Arch; 2015 Jul; 467(1):87-94. PubMed ID: 25820371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Relevance of Domain-Specific Phospholipase A
    Reinhard L; Zahner G; Menzel S; Koch-Nolte F; Stahl RAK; Hoxha E
    J Am Soc Nephrol; 2020 Jan; 31(1):197-207. PubMed ID: 31843985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-phospholipase A2 receptor antibodies and the pathogenesis of membranous nephropathy.
    Ronco P; Debiec H
    Nephron Clin Pract; 2014; 128(3-4):232-7. PubMed ID: 25401774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating (CD3(-)CD19(+)CD20(-)IgD(-)CD27(high)CD38(high)) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?
    Pozdzik A; Beukinga I; Gu-Trantien C; Willard-Gallo K; Nortier J; Pradier O
    Mediators Inflamm; 2016; 2016():7651024. PubMed ID: 27493452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current insights into functions of phospholipase A2 receptor in normal and cancer cells: More questions than answers.
    Sukocheva O; Menschikowski M; Hagelgans A; Yarla NS; Siegert G; Reddanna P; Bishayee A
    Semin Cancer Biol; 2019 Jun; 56():116-127. PubMed ID: 29104026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a bona fide animal model of PLA2R1-associated membranous nephropathy: one step forward.
    Bihl F; Lambeau G
    Kidney Int; 2023 Feb; 103(2):251-253. PubMed ID: 36681452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy.
    Coenen MJ; Hofstra JM; Debiec H; Stanescu HC; Medlar AJ; Stengel B; Boland-Augé A; Groothuismink JM; Bockenhauer D; Powis SH; Mathieson PW; Brenchley PE; Kleta R; Wetzels JF; Ronco P
    J Am Soc Nephrol; 2013 Mar; 24(4):677-83. PubMed ID: 23431073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of PLA2R1 in renal biopsy specimens of patients with idiopathic membranous nephropathy].
    Zhu SS; Zhou SL; Zhou CM; Li YQ; Zou HQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Apr; 35(4):526-9. PubMed ID: 25907937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients.
    Meyer-Schwesinger C; Tomas NM; Dehde S; Seifert L; Hermans-Borgmeyer I; Wiech T; Koch-Nolte F; Huber TB; Zahner G
    Kidney Int; 2020 May; 97(5):913-919. PubMed ID: 32033781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.
    Seitz-Polski B; Dolla G; Payré C; Girard CA; Polidori J; Zorzi K; Birgy-Barelli E; Jullien P; Courivaud C; Krummel T; Benzaken S; Bernard G; Burtey S; Mariat C; Esnault VL; Lambeau G
    J Am Soc Nephrol; 2016 May; 27(5):1517-33. PubMed ID: 26567246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice.
    Tomas NM; Dehde S; Meyer-Schwesinger C; Huang M; Hermans-Borgmeyer I; Maybaum J; Lucas R; von der Heide JL; Kretz O; Köllner SMS; Seifert L; Huber TB; Zahner G
    Kidney Int; 2023 Feb; 103(2):297-303. PubMed ID: 36191868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study.
    Timmermans SA; Damoiseaux JG; Heerings-Rewinkel PT; Ayalon R; Beck LH; Schlumberger W; Salant DJ; van Paassen P; Tervaert JW;
    Am J Clin Pathol; 2014 Jul; 142(1):29-34. PubMed ID: 24926082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.